chr12-111214217-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_015267.4(CUX2):c.81C>T(p.Val27=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00295 in 1,540,248 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0030 ( 11 hom. )
Consequence
CUX2
NM_015267.4 synonymous
NM_015267.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0730
Genes affected
CUX2 (HGNC:19347): (cut like homeobox 2) This gene encodes a protein which contains three CUT domains and a homeodomain; both domains are DNA-binding motifs. A similar gene, whose gene product possesses different DNA-binding activities, is located on chromosome on chromosome 7. Two pseudogenes of this gene have been identified on chromosomes 10 and 4. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 12-111214217-C-T is Benign according to our data. Variant chr12-111214217-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 713817.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.073 with no splicing effect.
BS2
High AC in GnomAd4 at 361 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CUX2 | NM_015267.4 | c.81C>T | p.Val27= | synonymous_variant | 2/22 | ENST00000261726.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CUX2 | ENST00000261726.11 | c.81C>T | p.Val27= | synonymous_variant | 2/22 | 1 | NM_015267.4 | P1 | |
CUX2 | ENST00000397643.3 | c.261C>T | p.Val87= | synonymous_variant | 3/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00246 AC: 361AN: 146586Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
361
AN:
146586
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00206 AC: 428AN: 207294Hom.: 0 AF XY: 0.00193 AC XY: 220AN XY: 113696
GnomAD3 exomes
AF:
AC:
428
AN:
207294
Hom.:
AF XY:
AC XY:
220
AN XY:
113696
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00300 AC: 4184AN: 1393588Hom.: 11 Cov.: 28 AF XY: 0.00298 AC XY: 2061AN XY: 691728
GnomAD4 exome
AF:
AC:
4184
AN:
1393588
Hom.:
Cov.:
28
AF XY:
AC XY:
2061
AN XY:
691728
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00246 AC: 361AN: 146660Hom.: 1 Cov.: 31 AF XY: 0.00233 AC XY: 166AN XY: 71112
GnomAD4 genome
AF:
AC:
361
AN:
146660
Hom.:
Cov.:
31
AF XY:
AC XY:
166
AN XY:
71112
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | CUX2: BP4, BP7 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Developmental and epileptic encephalopathy, 67 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 14, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at